Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

October 7, 2019

Overview

GDm-Health is a patient app-to-clinician software system that helps pregnant women and their care teams significantly improve the way they monitor and manage diabetes in pregnancy while minimising the need for additional face-to-face clinic appointments. Following a two-year clinical trial, GDm-Health is now available across the NHS and has been adopted by 15 NHS Trusts since its commercial launch in October 2018.

Purpose

As an evidence-based system born out of clinical need, GDm-Health is an example of data-driven technology that delivers benefits to the NHS and its patients safely and securely. Although GDm-Health was developed before the initial publication of the Department of Health’s Code of Conduct for Data-driven Health and Care Technologies, it is an exemplar of the principles of the Code in practice and is being used as a case study by NHSX.

The work

The Department of Health’s Code of Conduct comprises ten principles designed to help health and care providers choose safe, effective, secure technology to improve the services they provide. These include:

  • Principle 4: Be fair, transparent and accountable about what data is being used
  • Every NHS Trust that Sensyne Health works with has a Data Privacy Impact Assessment in place. When using GDm-Health, patients are informed of Sensyne Health’s use of anonymised data for research, the patient benefits this data provides and the opportunity to opt out via their NHS Trust. Data is never shared or sold to third parties. Importantly, each customer’s application and operational data is separate, meaning that Trusts which authorise the contribution of operational data to the common research data warehouse are reassured that no patient-identifiable information is shared.
  • Principle 9: Make security integral to the design
  • GDm-Health’s design follows the NHS Data Security and Protection 2018 Toolkit, using third parties to independently evaluate the security of the system. Security is integral to the design of all Sensyne Health products, and all products comply with the international standard for information security management. Any information being stored using GDm-Health in the device or in the server, and while it is being transferred to and from the app and Sensyne Health’s servers, is encrypted. Patients and clinicians can also communicate securely within the system.

Outcomes

GDm-Health is regarded as a gold-standard example by the NHS of how innovation and the responsible use of data directly assist clinicians and improve patient care. It has empowered women to better manage diabetes during pregnancy providing vital assistance and reassurance at what can be a worrying time. Since its launch over 4,000 women have benefited from using GDm-Health. There are currently over 900 active users across 15 NHS Trusts and every month an average of over 500 users start using the app.

Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

October 7, 2019

Overview

GDm-Health is a patient app-to-clinician software system that helps pregnant women and their care teams significantly improve the way they monitor and manage diabetes in pregnancy while minimising the need for additional face-to-face clinic appointments. Following a two-year clinical trial, GDm-Health is now available across the NHS and has been adopted by 15 NHS Trusts since its commercial launch in October 2018.

Purpose

As an evidence-based system born out of clinical need, GDm-Health is an example of data-driven technology that delivers benefits to the NHS and its patients safely and securely. Although GDm-Health was developed before the initial publication of the Department of Health’s Code of Conduct for Data-driven Health and Care Technologies, it is an exemplar of the principles of the Code in practice and is being used as a case study by NHSX.

The work

The Department of Health’s Code of Conduct comprises ten principles designed to help health and care providers choose safe, effective, secure technology to improve the services they provide. These include:

  • Principle 4: Be fair, transparent and accountable about what data is being used
  • Every NHS Trust that Sensyne Health works with has a Data Privacy Impact Assessment in place. When using GDm-Health, patients are informed of Sensyne Health’s use of anonymised data for research, the patient benefits this data provides and the opportunity to opt out via their NHS Trust. Data is never shared or sold to third parties. Importantly, each customer’s application and operational data is separate, meaning that Trusts which authorise the contribution of operational data to the common research data warehouse are reassured that no patient-identifiable information is shared.
  • Principle 9: Make security integral to the design
  • GDm-Health’s design follows the NHS Data Security and Protection 2018 Toolkit, using third parties to independently evaluate the security of the system. Security is integral to the design of all Sensyne Health products, and all products comply with the international standard for information security management. Any information being stored using GDm-Health in the device or in the server, and while it is being transferred to and from the app and Sensyne Health’s servers, is encrypted. Patients and clinicians can also communicate securely within the system.

Outcomes

GDm-Health is regarded as a gold-standard example by the NHS of how innovation and the responsible use of data directly assist clinicians and improve patient care. It has empowered women to better manage diabetes during pregnancy providing vital assistance and reassurance at what can be a worrying time. Since its launch over 4,000 women have benefited from using GDm-Health. There are currently over 900 active users across 15 NHS Trusts and every month an average of over 500 users start using the app.

Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

October 7, 2019

Overview

GDm-Health is a patient app-to-clinician software system that helps pregnant women and their care teams significantly improve the way they monitor and manage diabetes in pregnancy while minimising the need for additional face-to-face clinic appointments. Following a two-year clinical trial, GDm-Health is now available across the NHS and has been adopted by 15 NHS Trusts since its commercial launch in October 2018.

Purpose

As an evidence-based system born out of clinical need, GDm-Health is an example of data-driven technology that delivers benefits to the NHS and its patients safely and securely. Although GDm-Health was developed before the initial publication of the Department of Health’s Code of Conduct for Data-driven Health and Care Technologies, it is an exemplar of the principles of the Code in practice and is being used as a case study by NHSX.

The work

The Department of Health’s Code of Conduct comprises ten principles designed to help health and care providers choose safe, effective, secure technology to improve the services they provide. These include:

  • Principle 4: Be fair, transparent and accountable about what data is being used
  • Every NHS Trust that Sensyne Health works with has a Data Privacy Impact Assessment in place. When using GDm-Health, patients are informed of Sensyne Health’s use of anonymised data for research, the patient benefits this data provides and the opportunity to opt out via their NHS Trust. Data is never shared or sold to third parties. Importantly, each customer’s application and operational data is separate, meaning that Trusts which authorise the contribution of operational data to the common research data warehouse are reassured that no patient-identifiable information is shared.
  • Principle 9: Make security integral to the design
  • GDm-Health’s design follows the NHS Data Security and Protection 2018 Toolkit, using third parties to independently evaluate the security of the system. Security is integral to the design of all Sensyne Health products, and all products comply with the international standard for information security management. Any information being stored using GDm-Health in the device or in the server, and while it is being transferred to and from the app and Sensyne Health’s servers, is encrypted. Patients and clinicians can also communicate securely within the system.

Outcomes

GDm-Health is regarded as a gold-standard example by the NHS of how innovation and the responsible use of data directly assist clinicians and improve patient care. It has empowered women to better manage diabetes during pregnancy providing vital assistance and reassurance at what can be a worrying time. Since its launch over 4,000 women have benefited from using GDm-Health. There are currently over 900 active users across 15 NHS Trusts and every month an average of over 500 users start using the app.

Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

Overview

GDm-Health is a patient app-to-clinician software system that helps pregnant women and their care teams significantly improve the way they monitor and manage diabetes in pregnancy while minimising the need for additional face-to-face clinic appointments. Following a two-year clinical trial, GDm-Health is now available across the NHS and has been adopted by 15 NHS Trusts since its commercial launch in October 2018.

Purpose

As an evidence-based system born out of clinical need, GDm-Health is an example of data-driven technology that delivers benefits to the NHS and its patients safely and securely. Although GDm-Health was developed before the initial publication of the Department of Health’s Code of Conduct for Data-driven Health and Care Technologies, it is an exemplar of the principles of the Code in practice and is being used as a case study by NHSX.

The work

The Department of Health’s Code of Conduct comprises ten principles designed to help health and care providers choose safe, effective, secure technology to improve the services they provide. These include:

  • Principle 4: Be fair, transparent and accountable about what data is being used
  • Every NHS Trust that Sensyne Health works with has a Data Privacy Impact Assessment in place. When using GDm-Health, patients are informed of Sensyne Health’s use of anonymised data for research, the patient benefits this data provides and the opportunity to opt out via their NHS Trust. Data is never shared or sold to third parties. Importantly, each customer’s application and operational data is separate, meaning that Trusts which authorise the contribution of operational data to the common research data warehouse are reassured that no patient-identifiable information is shared.
  • Principle 9: Make security integral to the design
  • GDm-Health’s design follows the NHS Data Security and Protection 2018 Toolkit, using third parties to independently evaluate the security of the system. Security is integral to the design of all Sensyne Health products, and all products comply with the international standard for information security management. Any information being stored using GDm-Health in the device or in the server, and while it is being transferred to and from the app and Sensyne Health’s servers, is encrypted. Patients and clinicians can also communicate securely within the system.

Outcomes

GDm-Health is regarded as a gold-standard example by the NHS of how innovation and the responsible use of data directly assist clinicians and improve patient care. It has empowered women to better manage diabetes during pregnancy providing vital assistance and reassurance at what can be a worrying time. Since its launch over 4,000 women have benefited from using GDm-Health. There are currently over 900 active users across 15 NHS Trusts and every month an average of over 500 users start using the app.

Meet us at event
Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

October 7, 2019

Overview

GDm-Health is a patient app-to-clinician software system that helps pregnant women and their care teams significantly improve the way they monitor and manage diabetes in pregnancy while minimising the need for additional face-to-face clinic appointments. Following a two-year clinical trial, GDm-Health is now available across the NHS and has been adopted by 15 NHS Trusts since its commercial launch in October 2018.

Purpose

As an evidence-based system born out of clinical need, GDm-Health is an example of data-driven technology that delivers benefits to the NHS and its patients safely and securely. Although GDm-Health was developed before the initial publication of the Department of Health’s Code of Conduct for Data-driven Health and Care Technologies, it is an exemplar of the principles of the Code in practice and is being used as a case study by NHSX.

The work

The Department of Health’s Code of Conduct comprises ten principles designed to help health and care providers choose safe, effective, secure technology to improve the services they provide. These include:

  • Principle 4: Be fair, transparent and accountable about what data is being used
  • Every NHS Trust that Sensyne Health works with has a Data Privacy Impact Assessment in place. When using GDm-Health, patients are informed of Sensyne Health’s use of anonymised data for research, the patient benefits this data provides and the opportunity to opt out via their NHS Trust. Data is never shared or sold to third parties. Importantly, each customer’s application and operational data is separate, meaning that Trusts which authorise the contribution of operational data to the common research data warehouse are reassured that no patient-identifiable information is shared.
  • Principle 9: Make security integral to the design
  • GDm-Health’s design follows the NHS Data Security and Protection 2018 Toolkit, using third parties to independently evaluate the security of the system. Security is integral to the design of all Sensyne Health products, and all products comply with the international standard for information security management. Any information being stored using GDm-Health in the device or in the server, and while it is being transferred to and from the app and Sensyne Health’s servers, is encrypted. Patients and clinicians can also communicate securely within the system.

Outcomes

GDm-Health is regarded as a gold-standard example by the NHS of how innovation and the responsible use of data directly assist clinicians and improve patient care. It has empowered women to better manage diabetes during pregnancy providing vital assistance and reassurance at what can be a worrying time. Since its launch over 4,000 women have benefited from using GDm-Health. There are currently over 900 active users across 15 NHS Trusts and every month an average of over 500 users start using the app.